Abstract
Purpose
Platelet count is inversely related to prognosis in many cancers; however, its role in esophageal cancer is still controversial. The purpose of this study was to determine the prognostic value of preoperative platelet count in esophageal squamous cell carcinoma (ESCC).
Methods
From January 2006 to December 2008, a retrospective analysis of 425 consecutive patients with ESCC was conducted. A receiver operating characteristic (ROC) curve for survival prediction was plotted to verify the optimum cutoff point for preoperative platelet count. Univariate and multivariate analyses were performed to evaluate the prognostic parameters.
Results
A ROC curve for survival prediction was plotted to verify the optimum cutoff point for platelet count, which was 205 (×109/L). Patients with platelet count ≤205 had a significantly better 5-year survival than patients with a platelet count >205 (60.7 vs. 31.6 %, P < 0.001). The 5-year survival of patients either with platelet count ≤205 or >205 were similar (68.6 vs. 58.8 %, P = 0.085) when the nodes were negative. However, the 5-year survival of patients with platelet count ≤205 was better than that of patients with a platelet count >205 when the nodes were involved (32.0 vs. 12.7 %, P = 0.004). Multivariate analysis showed that platelet count (P = 0.013), T grade (P = 0.017), and N staging (P < 0.001) were independent prognostic factors.
Conclusions
Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×109/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.
Similar content being viewed by others
References
Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2897
Ministry of Health of the people’s republic of China (2008) Report of the third national retrospective survey of death causes in China. Chinese Academy of Medical Sciences & Peking Union Medical College Press, Beijing, Chinese
Peyre CG, Hagen JA, DeMeester SR et al (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248(4):549–556
Wijnhoven BP, Tran KT, Esterman A et al (2007) An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 245(5):717–725
Monreal M, Fernandez-Llamazares J, Piñol M et al (1998) Platelet count and survival in patients with colorectal cancer: a preliminary study. Thromb Haemost 79(5):916–918, PMID: 9609220
Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9(9):1826–1830
Shimada H, Oohira G, Okazumi S et al (2004) Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198(5):737–741
Aminian A, Karimian F, Mirsharifi R et al (2011) Significance of platelet count in esophageal carcinomas. Saudi J Gastroenterol 17(2):134–137
Dutta S, Crumley AB, Fullarton GM et al (2011) Comparison of the prognostic value of tumour- and patient- related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg 35(8):1861–1866
Rice TW, Rusch VW, Ishwaran H et al (2010) Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals. Cancer 116(16):3763–3773, PMID: 20564099
Ling FC, Vallböhmer D, Hoelscher AH et al (2010) Increased platelet counts after transthoracic en bloc resection for esophageal cancer is associated with significantly improved survival. World J Surg 34(11):2628–2634
Blair P, Flaumenhaft R (2009) Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 23(4):177–189
Borsig L (2008) The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8(8):1247–1255
Dineen SP, Roland CL, Toombs JE et al (2009) The acellular fraction of stored platelets promotes tumor cell invasion. J Surg Res 153(1):132–137
Pipili-Synetos E, Papadimitriou E, Maragoudakis ME (1998) Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol 125(6):1252–1257
Placke T, Kopp HG, Salih HR (2011) Modulation of natural killer cell anti-tumor reactivity by platelets. J Innate Immun 3(4):374–382
Nieswandt B, Hafner M, Echtenacher B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59(6):1295–1300
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feng, J.F., Huang, Y., Lu, W.S. et al. Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor?. Langenbecks Arch Surg 398, 1115–1122 (2013). https://doi.org/10.1007/s00423-013-1111-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-013-1111-4